Despite significant dips in its vaccines sales, the British pharma narrowly beat consensus estimates for Q4 2024 and raised ...

Trump has claimed the U.S. can no longer suffer the massive trade deficits and subsidies that he says Canada needs to stay ...

Financial writer recommends Merck & Co., Inc. as a strong healthcare stock despite recent challenges, citing strong potential ...

Should you take a vitamin B complex supplement with all eight B vitamins or a supplement with B12 alone? This article helps ...

Beijing hit back with its own tariffs and export restrictions after being subjected to levies by President Trump. Trade ...

Through messages, Paul had remained largely upbeat in the face of a terminal prognosis, showing us that he was still a ...

President Donald Trump signed an executive action he said would direct officials to create a sovereign wealth fund for the ...

Bristol-Myers Squibb gets rated a hold, as I see future value in its clinical portfolio and pipeline, particularly ...

Two members of Connecticut’s congressional delegation said they hope President Donald Trump will rethink his proposed tariffs before they “leave massive wounds on our economy.” ...

Learn more about whether Qiagen N.V. or Repligen Corporation is a better investment based on AAII's A+ Investor grades, which ...

FY25 Blinklab initiated an FDA registrational study of its Dx 1 platform as an aid in autism diagnosis, plus more biotech ...

REDWOOD CITY, Calif. - Rezolute , Inc. (NASDAQ:RZLT), a biopharmaceutical company with a market capitalization of $303.62 million and impressive recent momentum (up 13.91% in the past week), announced ...